JP2007502684A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502684A5 JP2007502684A5 JP2006530185A JP2006530185A JP2007502684A5 JP 2007502684 A5 JP2007502684 A5 JP 2007502684A5 JP 2006530185 A JP2006530185 A JP 2006530185A JP 2006530185 A JP2006530185 A JP 2006530185A JP 2007502684 A5 JP2007502684 A5 JP 2007502684A5
- Authority
- JP
- Japan
- Prior art keywords
- container
- container according
- vial
- pharmaceutical composition
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000463 material Substances 0.000 claims description 6
- 239000004809 Teflon Substances 0.000 claims description 2
- 229920006362 Teflon® Polymers 0.000 claims description 2
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical group OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims 3
- 239000000022 bacteriostatic agent Substances 0.000 claims 3
- 102000003996 Interferon-beta Human genes 0.000 claims 2
- 108090000467 Interferon-beta Proteins 0.000 claims 2
- 239000003708 ampul Substances 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 229960001388 interferon-beta Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229940071643 prefilled syringe Drugs 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000019445 benzyl alcohol Nutrition 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000007951 isotonicity adjuster Substances 0.000 claims 1
- 239000012263 liquid product Substances 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- KKEBXNMGHUCPEZ-UHFFFAOYSA-N 4-phenyl-1-(2-sulfanylethyl)imidazolidin-2-one Chemical compound N1C(=O)N(CCS)CC1C1=CC=CC=C1 KKEBXNMGHUCPEZ-UHFFFAOYSA-N 0.000 description 2
- 239000011123 type I (borosilicate glass) Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03010671 | 2003-05-13 | ||
| PCT/EP2004/050779 WO2004100979A2 (en) | 2003-05-13 | 2004-05-12 | Liquid stabilized protein formulations in coated pharmaceutical containers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012005485A Division JP2012096063A (ja) | 2003-05-13 | 2012-01-13 | 医薬容器内の安定化した液体タンパク質の処方物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502684A JP2007502684A (ja) | 2007-02-15 |
| JP2007502684A5 true JP2007502684A5 (cg-RX-API-DMAC7.html) | 2012-03-08 |
Family
ID=33442722
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530185A Withdrawn JP2007502684A (ja) | 2003-05-13 | 2004-05-12 | 医薬容器内の安定化した液体タンパク質の処方物(formulation) |
| JP2012005485A Pending JP2012096063A (ja) | 2003-05-13 | 2012-01-13 | 医薬容器内の安定化した液体タンパク質の処方物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012005485A Pending JP2012096063A (ja) | 2003-05-13 | 2012-01-13 | 医薬容器内の安定化した液体タンパク質の処方物 |
Country Status (22)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7879320B2 (en) * | 2004-05-17 | 2011-02-01 | Ares Trading S.A. | Hydrogel interferon formulations |
| US7731948B2 (en) * | 2004-06-01 | 2010-06-08 | Ares Trading S.A. | Stabilized interferon liquid formulations |
| EP1845925B1 (en) | 2005-01-12 | 2016-08-24 | Biogen MA Inc. | Method for delivering interferon-beta |
| CA2615731A1 (en) * | 2005-07-29 | 2007-02-08 | Amgen Inc. | Formulations that inhibit protein aggregation |
| US20070253985A1 (en) * | 2006-04-26 | 2007-11-01 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| KR100785070B1 (ko) | 2006-07-11 | 2007-12-12 | 삼성전자주식회사 | 휴대 단말기에서 디지털 저작권 관리 콘텐츠 재생 방법 및장치 |
| AU2008269086B2 (en) | 2007-06-25 | 2014-06-12 | Amgen Inc. | Compositions of specific binding agents to hepatocyte growth factor |
| RS52417B (sr) * | 2007-12-20 | 2013-02-28 | Merck Serono S.A. | Formulacije peg-interferona-beta |
| WO2010056804A1 (en) | 2008-11-12 | 2010-05-20 | Medimmune, Llc | Antibody formulation |
| CN107095846A (zh) | 2009-12-21 | 2017-08-29 | 霍夫曼-拉罗奇有限公司 | 抗体配制剂 |
| US8802603B2 (en) | 2010-06-17 | 2014-08-12 | Becton, Dickinson And Company | Medical components having coated surfaces exhibiting low friction and low reactivity |
| WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
| FR2966044B1 (fr) * | 2010-10-18 | 2012-11-02 | Sanofi Pasteur | Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium |
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| CA2890933C (en) | 2012-12-03 | 2021-06-08 | Novobiotic Pharmaceuticals, Llc | Novel depsipeptide and uses thereof |
| BR112015017307A2 (pt) | 2013-03-14 | 2017-11-21 | Abbvie Inc | composições de espécies com baixa acidez e métodos para produção e uso das mesmas |
| WO2014159554A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | Low acidic species compositions and methods for producing the same using displacement chromatography |
| PT3613423T (pt) | 2013-07-10 | 2022-12-07 | Matrix Biology Inst | Composições de hialuronano de elevada elasticidade e suas utilizações |
| WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
| JP6685897B2 (ja) * | 2014-03-13 | 2020-04-22 | ステヴァナト グループ インターナショナル エイ.エス. | 液体製剤を処理する方法 |
| US20170226552A1 (en) | 2014-07-03 | 2017-08-10 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt |
| US20160185848A1 (en) | 2014-07-09 | 2016-06-30 | Abbvie Inc. | Methods for modulating the glycosylation profile of recombinant proteins using sugars |
| WO2016144773A1 (en) | 2015-03-06 | 2016-09-15 | Abbvie Inc. | Arabinosylated glycoproteins |
| WO2016163764A2 (ko) * | 2015-04-07 | 2016-10-13 | 에이비온 주식회사 | 인터페론 베타 변이체의 안정화 제제 |
| PT3352766T (pt) | 2015-09-24 | 2022-03-22 | Matrix Biology Inst | Composições de hialuronano de elevada elasticidade e processos para o seu uso |
| WO2017147003A1 (en) | 2016-02-26 | 2017-08-31 | Novobiotic Pharmaceuticals, Llc | Novel macrocyclic antibiotics and uses thereof |
| FI126979B (en) | 2016-02-29 | 2017-09-15 | Faron Pharmaceuticals Oy | Lyophilized pharmaceutical formulation and its use |
| ES2981759T3 (es) | 2017-04-04 | 2024-10-10 | Novobiotic Pharmaceuticals Llc | Nuevos depsipéptidos y sus usos |
| US12629445B2 (en) | 2020-03-20 | 2026-05-19 | Bard Peripheral Vascular, Inc. | Reactive hydrogel forming formulations and related methods, including methods of preparation |
| US12161777B2 (en) | 2020-07-02 | 2024-12-10 | Davol Inc. | Flowable hemostatic suspension |
| US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
| WO2022146917A1 (en) | 2020-12-28 | 2022-07-07 | Davol Inc. | Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2622598A (en) | 1951-03-08 | 1952-12-23 | Premo Pharmaceutical Lab Inc | Drain-clear container for aqueous liquid pharmaceutical preparations |
| US5183746A (en) * | 1986-10-27 | 1993-02-02 | Schering Aktiengesellschaft | Formulation processes for pharmaceutical compositions of recombinant β- |
| JP3332379B2 (ja) | 1992-05-06 | 2002-10-07 | マリンクロッド・インコーポレイテッド | 次亜塩素酸ナトリウム溶液の安定性保持用容器封鎖物システム |
| US5661125A (en) | 1992-08-06 | 1997-08-26 | Amgen, Inc. | Stable and preserved erythropoietin compositions |
| TW249202B (cg-RX-API-DMAC7.html) * | 1993-08-13 | 1995-06-11 | Ciba Gerigy Corp | |
| TW426523B (en) * | 1995-04-06 | 2001-03-21 | Hoffmann La Roche | Interferon solution |
| JP4057058B2 (ja) | 1995-11-07 | 2008-03-05 | ジェネンテック インコーポレーテッド | Ngfの安定化処方 |
| US6142977A (en) | 1996-10-18 | 2000-11-07 | Schering Ag | Prefilled, sterilized syringe with a new and improved plug |
| DE69729880T3 (de) * | 1996-12-24 | 2012-05-10 | Biogen Idec Ma Inc. | Stabile flüssige interferon-zubereitungen |
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| CN2326243Y (zh) | 1997-09-29 | 1999-06-30 | 程继勇 | 覆膜药用瓶塞 |
| US6667299B1 (en) | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
| CN2441750Y (zh) * | 2000-06-23 | 2001-08-08 | 程继勇 | 表面覆膜药用橡胶瓶塞 |
| JP2002209975A (ja) * | 2001-01-19 | 2002-07-30 | Daikyo Seiko Ltd | 医薬バイアル用ラミネートゴム栓 |
| CN1133565C (zh) * | 2001-10-18 | 2004-01-07 | 郑秀娣 | 药品瓶塞隔离膜 |
-
2004
- 2004-05-11 AR ARP040101607 patent/AR044302A1/es not_active Application Discontinuation
- 2004-05-12 PL PL04760770T patent/PL1633388T3/pl unknown
- 2004-05-12 EP EP20110152658 patent/EP2324845A1/en not_active Withdrawn
- 2004-05-12 PT PT04760770T patent/PT1633388E/pt unknown
- 2004-05-12 CA CA 2523477 patent/CA2523477A1/en not_active Withdrawn
- 2004-05-12 DK DK04760770T patent/DK1633388T3/da active
- 2004-05-12 MX MXPA05012191A patent/MXPA05012191A/es active IP Right Grant
- 2004-05-12 SI SI200432149T patent/SI1633388T1/sl unknown
- 2004-05-12 US US13/151,459 patent/USRE43331E1/en not_active Expired - Lifetime
- 2004-05-12 JP JP2006530185A patent/JP2007502684A/ja not_active Withdrawn
- 2004-05-12 WO PCT/EP2004/050779 patent/WO2004100979A2/en not_active Ceased
- 2004-05-12 EP EP04760770.0A patent/EP1633388B1/en not_active Expired - Lifetime
- 2004-05-12 UA UAA200510442A patent/UA91493C2/uk unknown
- 2004-05-12 US US10/556,467 patent/US7540382B2/en not_active Ceased
- 2004-05-12 HR HRP20140267TT patent/HRP20140267T1/hr unknown
- 2004-05-12 CN CN2004800169917A patent/CN1809376B/zh not_active Expired - Lifetime
- 2004-05-12 BR BRPI0410679 patent/BRPI0410679A/pt not_active IP Right Cessation
- 2004-05-12 EA EA200501692A patent/EA008308B1/ru not_active IP Right Cessation
- 2004-05-12 AU AU2004237982A patent/AU2004237982C1/en not_active Expired
- 2004-05-12 ES ES04760770.0T patent/ES2471942T3/es not_active Expired - Lifetime
- 2004-05-12 KR KR20057021160A patent/KR101084412B1/ko not_active Expired - Fee Related
-
2005
- 2005-11-13 IL IL17191205A patent/IL171912A/en active IP Right Grant
- 2005-12-06 NO NO20055774A patent/NO20055774D0/no not_active Application Discontinuation
-
2012
- 2012-01-13 JP JP2012005485A patent/JP2012096063A/ja active Pending
-
2014
- 2014-05-30 CY CY20141100386T patent/CY1115233T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20140267T1 (hr) | Tekuä†e stabilizirane formulacije interferona-beta u obloženim farmaceutskim spremnicima | |
| FI3506886T3 (fi) | Erittäin väkevöityjä alhaisen viskositeetin masp-2:ta estäviä vasta-aineformulaatioita, tarvikesarjoja ja menetelmiä | |
| HRP20171894T1 (hr) | Kombinacija inzulina i agonista glp-1 | |
| MX2021007393A (es) | Formulacion de solucion de proteinas que contiene una alta concentracion de un anticuerpo anti-vegf. | |
| CN109010803A (zh) | 一种重组人干扰素α2b滴眼液及其制备方法 | |
| CN112004521A (zh) | 用于递送胰岛素化合物的医用输注泵系统 | |
| DK2624865T3 (en) | Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies | |
| WO2019193351A1 (en) | Medical infusion pump system for the delivery of an insulin compound | |
| JP6445169B2 (ja) | α型インターフェロンを含有する安定したベンジルアルコールフリーの水溶液製剤 | |
| JP2001278788A (ja) | アラントインを配合した安定な液剤 | |
| JPS61221125A (ja) | ペプタイドの吸着防止組成物 | |
| WO2019176239A1 (ja) | 容器充填ヒトpth(1-34)液体医薬組成物及びその製造方法 | |
| JP4707327B2 (ja) | ポリペプタイド類の吸着防止剤 | |
| TH102367A (th) | สูตรผสมอินเตอร์เฟียรอนที่เป็นของเหลวซึ่งถูกทำให้เสถียรโดยปลอด hsa | |
| TH73258B (th) | สูตรผสมอินเตอร์เฟียรอนที่เป็นของเหลวซึ่งถูกทำให้เสถียรโดยปลอด hsa | |
| JPS60100524A (ja) | ペプタイド吸着防止組成物および方法 | |
| JP2000290195A (ja) | カルシトニン類のプレフィルドシリンジ製剤 | |
| HK1242218A1 (en) | Stable, benzyl alcohol-free aqueous solution formulations containing alpha-type interferon | |
| JPS5976024A (ja) | インシユリン吸着防止組成物および方法 |